Masimo (MASI) Reports Q4 Earnings: What Key Metrics Have to Say

Core Insights - Masimo reported revenue of $600.7 million for the quarter ended December 2024, reflecting a year-over-year increase of 9.4% [1] - The company's EPS was $1.80, up from $1.25 in the same quarter last year, indicating a significant improvement [1] - The reported revenue exceeded the Zacks Consensus Estimate of $596.07 million, resulting in a surprise of +0.78% [1] - Masimo delivered an EPS surprise of +20.81%, with the consensus EPS estimate being $1.49 [1] Revenue Breakdown - Non-healthcare revenue was $232.20 million, surpassing the average estimate of $224.29 million, marking an 11.1% year-over-year increase [4] - Healthcare revenue reached $368.50 million, slightly below the estimated $369.46 million, but still showing an 8.4% increase compared to the previous year [4] Profit Metrics - Gross profit from non-healthcare was reported at $81 million, exceeding the average estimate of $77.12 million [4] - Gross profit from healthcare was $232.30 million, which was below the estimated $236.40 million [4] Stock Performance - Over the past month, Masimo's shares returned +0.1%, while the Zacks S&P 500 composite declined by -1.8% [3] - The stock currently holds a Zacks Rank 2 (Buy), suggesting potential outperformance against the broader market in the near term [3]